Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioLeap

BioLeap
2004 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of drug designing services. The company identifies and optimizes lead compounds using its technology platform. It offers a proprietary technology platform to identify and optimize lead compounds to discover novel drugs.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 238 West Delaware Avenue
  • Pennington, NJ 08534
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioLeap’s full profile, request a free trial.

BioLeap Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jun-2015 00.00 Completed Profitable
4. Grant 18-Oct-2013 00000 00.00 Completed Profitable
3. Later Stage VC 05-Apr-2011 000 00.00 Completed Profitable
2. Early Stage VC (Series A) 12-Jan-2010 $5M $5.4M 000.00 Completed Profitable
1. Corporate 01-Jan-2009 $400K $400K Completed
To view this company’s complete deal history including valuation and funding, request access »

BioLeap Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

BioLeap Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Adams Capital Management Venture Capital Minority 000 0000 000000 0
Peakdale Molecular Corporation Minority 000 0000 000000 0
Quaker Partners Venture Capital Minority 000 0000 000000 0
Syngenta Ventures Corporate Venture Capital Minority 000 0000 000000 0

BioLeap Executive Team (4)

Name Title Board
Seat
Contact
Info
Ian Cloudsdale Vice President, Chemistry

3 Former Executives

You’re viewing 1 of 4 executives. Get the full list »

BioLeap Board Members (6)

Name Representing Role Since Contact
Info
Anthony Ford-Hutchinson Ph.D Self Director 000 0000

5 Former Board Members

You’re viewing 1 of 6 board members. Get the full list »